MedTrace Logo

Screening Latent Tuberculosis Infection and Observing Preventive Therapy in Kidney Transplantation

NCT02782416 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 800

Last updated 2016-12-15

No results posted yet for this study

Summary

Study the prevalence of LTBI in patients who are waiting renal transplant and monitor the incidence of active TB

Conditions

  • Kidney Transplantation

Interventions

OTHER

Examination of latent tuberculosis

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Chin-Chung Shu, MD · National Taiwan University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02782416 on ClinicalTrials.gov